MedTrace Logo

Neurodynamic Mobilization for Cervical Radiculopathy

NCT07643701 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-06-12

No results posted yet for this study

Summary

Cervical radiculopathy is a condition caused by compression or irritation of cervical nerve roots, leading to neck pain, arm pain, sensory disturbances, and functional limitations. This randomized controlled trial evaluated whether adding neurodynamic mobilization to conventional physiotherapy improves pain intensity and functional disability in individuals with cervical radiculopathy. Participants received either conventional physiotherapy alone or conventional physiotherapy combined with neurodynamic mobilization over a 5-week treatment period.

Conditions

  • Cervical Radiculopathy

Interventions

OTHER

neurodynamic mobilization

Neurodynamic mobilization consisted of specific neural tissue mobilization techniques targeting the affected cervical nerve roots. The techniques were applied in addition to conventional physiotherapy and aimed to restore normal neural mobility and reduce mechanosensitivity. Treatment was delivered over 5 weeks (10 sessions). Each session included standardized neurodynamic sliding techniques performed within pain-free or low-pain ranges, combined with conventional physiotherapy interventions including therapeutic exercises, manual therapy, and physical modalities. The intervention was individually tailored based on patient symptoms and clinical presentation.

OTHER

conventional physiotherapy

Conventional physiotherapy consisted of a standardized rehabilitation program including therapeutic exercises, manual therapy techniques, and physical modalities. Therapeutic exercises focused on cervical range of motion, strengthening, and postural correction. Manual therapy included soft tissue techniques and joint mobilization of the cervical spine. Physical modalities were applied to reduce pain and improve function. The intervention was delivered over 5 weeks, with a total of 10 sessions.

Sponsors & Collaborators

  • Lebanese German University

    lead OTHER

Principal Investigators

  • Samir Matar, Professor · Lebanese German University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2025-02-28
Completion
2025-02-28

Countries

  • Lebanon

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07643701 on ClinicalTrials.gov